Sobre mí

Dr. Joan-Marc Servitja is a senior researcher at the group Pathogenesis and Prevention of Diabetes, leading different projects related to islet biology and diabetes. He has also received contracts from the pharmaceutical industry in order to test novel applications of existing drugs as potential treatments for type 1 and type 2 diabetes. During the last years, he has authored more than 20 articles on diabetes research published in high impact journals. Currently, he is leading different research lines focused on the regulation of gene expression and inter-organ cross-talk in pancreatic islets with the ultimate goal to design novel therapeutic strategies for the treatment of type 2 diabetes.

Publicaciones destacadas

Proyectos destacados

  • Inter-organ cross-talk and type 2 diabetes: effects of circulating exosomes on pancreatic islets

    Investigador/a principal: Anna Maria Novials Sarda, Joan Marc Servitja Duque
    Financiador: Instituto de Salud Carlos III
    Código: PI20/00658
    Duración: 01/01/2021 - 31/12/2023
  • Benchtop NMR for Lab-On-Chip (BLOC)

    Investigador/a principal: Joan Marc Servitja Duque
    Financiador: European Commission
    Código: 863037
    Duración: 01/01/2020 - 31/12/2023
  • BACE2, una nueva diana terapéutica para el tratamiento de la diabetes tipo 2 y la obesidad.

    Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Financiador: Instituto de Salud Carlos III
    Código: PI17/00879
    Duración: 01/01/2018 - 31/12/2020
  • Effects of physical exercise implementation in type 2 diabetes: extracellular vesicles as biomarkers and response mediators in cardiovascular protection

    Investigador/a principal: Joan Marc Servitja Duque, Carlos Gómez, Joan-Marc Servitja
    Financiador: Instituto de Salud Carlos III
    Código: PI23/00514
    Duración: 01/01/2024 - 31/12/2026
  • Effects of circulating extracellular vesicles on pancreatic islets during obesity

    Investigador/a principal: Joan Marc Servitja Duque
    Financiador: European Federation for the Study of Diebetes
    Código: EFSD/BI/2023
    Duración: 09/01/2023 - 31/01/2026